DR Horton Net Asset
| DHI Stock | USD 147.63 1.66 1.14% |
| = | 35.47 B |
DR Horton's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets are sold, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset | = | Current Market Value | - | Current Liabilities |
Current DR Horton Net Asset | 35.47 B |
Core metrics such as Net Asset form the backbone of any value-based review of DR Horton. This analysis gives context for investors weighing whether DR Horton's current price level is fair. Cross-checking multiple valuation measures reduces the risk of drawing conclusions from one metric's blind spots. DR Horton currently trades at a P/E of 5.10, which provides additional valuation context. The data shown here supports a structured approach to valuation analysis for DR Horton. A price-to-book ratio of 1.76 helps frame the market's assessment of DR Horton's asset base.
| Competition |
Fundamental Drivers Relationships
Net Asset Peer Comparison
Stock peer comparison using Net Asset is a widely accepted framework for evaluating DR Horton within its group. Investors who find DR Horton's Net Asset more favorable than peers may view DR Horton as attractively valued. Peer dispersion in Net Asset across the group provides context for evaluating DR Horton's competitive positioning.DR Horton is currently under evaluation for net asset among direct rivals.
Important Fundamentals
| Return On Equity TTM | 0.13 | |||
| Return On Asset TTM | 0.073 | |||
| Profit Margin TTM | 0.0951 | |||
| Operating Margin TTM | 0.11 | |||
| Current Valuation | 46.25 B | |||
| Shares Outstanding | 283.58 M | |||
| Shares Owned By Insiders | 11.57 % | |||
| Shares Owned By Institutions | 89.43 % | |||
| Number Of Shares Shorted | 15.42 M | |||
| Price To Earnings TTM | 5.10 X | |||
| Price To Book TTM | 1.76 X | |||
| Price To Sales TTM | 1.27 X | |||
| Revenue TTM | 34.25 B | |||
| Gross Profit TTM | 7.2 B | |||
| EBITDA TTM | 4.84 B | |||
| Net Income TTM | 3.59 B | |||
| Cash And Equivalents TTM | 2.99 B | |||
| Cash Per Share TTM | 7.08 X | |||
| Total Debt TTM | 6.03 B | |||
| Debt To Equity TTM | 0.31 % | |||
| Current Ratio TTM | 5.24 X | |||
| Book Value Per Share TTM | 82.92 X | |||
| Cash Flow From Operations TTM | 3.42 B | |||
| Short Ratio TTM | 5.55 X | |||
| Earnings Per Share | 10.65 X | |||
| Price To Earnings To Growth | 1.37 X | |||
| Target Price | 165.29 | |||
| Number Of Employees | 14.34 K | |||
| Trailing Beta | 1.41 | |||
| Market Capitalization TTM | 42.3 B | |||
| Total Asset TTM | 35.47 B | |||
| Retained Earnings TTM | 31.04 B | |||
| Working Capital TTM | 32.18 B | |||
| Current Asset TTM | 9.78 B | |||
| Current Liabilities TTM | 849.2 M | |||
| Annual Yield | 0.0121 | |||
| Five Year Return | 1.11 % | |||
| Net Asset | 35.47 B | |||
| Last Dividend Paid | 1.7 |
Financial Metrics, Fundamentals & Methodology
DR Horton's operating framework helps explain margin behavior, earnings persistence, and funding capacity. Debt exposure shapes how much financial pressure DR Horton could face in weaker periods. In recent filings, DR Horton reported revenue of 34.25 billion, positive EPS of 10.65, operating margin of 11.26% as of the latest reporting period.
DR Horton metrics are compiled from periodic company reporting and market reference feeds and normalized before display. Analyst projections are included when active coverage applies. Accounting-line values follow GAAP or IFRS structures as published in issuer filings.
Editorial review and methodology oversight provided by: Gabriel Shpitalnik, Member of Macroaxis Editorial Board